TY - JOUR
T1 - A set of external reference controls/probes that enable quality assurance between different microarray platforms
AU - Akiyama, Hideo
AU - Ueda, Yoji
AU - Nobumasa, Hitoshi
AU - Ooshima, Hiroyuki
AU - Ishizawa, Yohei
AU - Kitahiro, Koji
AU - Miyagawa, Isao
AU - Watanabe, Kazufumi
AU - Nakamura, Takazumi
AU - Tanaka, Ritsuka
AU - Yamamoto, Nobuko
AU - Nakae, Hiroki
AU - Kawase, Mitsuo
AU - Gemma, Nobuhiro
AU - Sekiguchi, Yuji
AU - Fujibuchi, Wataru
AU - Matoba, Ryo
N1 - Funding Information:
We thank Ayumi Hasegawa (Sumika Chemical Analysis Service) for the design of data analysis and Tatsunobu Fukushima (Mitsubishi Chemical Holdings) for helpful discussion during this work. We also acknowledge support from a New Energy and Industrial Technology Development Organization (NEDO) grant (NEDO 10001779-0) funded by the Ministry of Economy, Trade and Industry – Japan. We also thank Dr. Keith Hart, Cardiff University and members of Japan MicroArray Consortium (JMAC) for helpful discussion in this work.
Publisher Copyright:
© 2014 Elsevier Inc. All rights reserved.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - RNA external standards, although important to ensure equivalence across many microarray platforms, have yet to be fully implemented in the research community. In this article, a set of unique RNA external standards (or RNA standards) and probe pairs that were added to total RNA in the samples before amplification and labeling are described. Concentration-response curves of RNA external standards were used across multiple commercial DNA microarray platforms and/or quantitative real-time polymerase chain reaction (RT-PCR) and next-generation sequencing to identify problematic assays and potential sources of variation in the analytical process. A variety of standards can be added in a range of concentrations spanning high and low abundances, thereby enabling the evaluation of assay performance across the expected range of concentrations found in a clinical sample. Using this approach, we show that we are able to confirm the dynamic range and the limit of detection for each DNA microarray platform, RT-PCR protocol, and next-generation sequencer. In addition, the combination of a series of standards and their probes was investigated on each platform, demonstrating that multiplatform calibration and validation is possible.
AB - RNA external standards, although important to ensure equivalence across many microarray platforms, have yet to be fully implemented in the research community. In this article, a set of unique RNA external standards (or RNA standards) and probe pairs that were added to total RNA in the samples before amplification and labeling are described. Concentration-response curves of RNA external standards were used across multiple commercial DNA microarray platforms and/or quantitative real-time polymerase chain reaction (RT-PCR) and next-generation sequencing to identify problematic assays and potential sources of variation in the analytical process. A variety of standards can be added in a range of concentrations spanning high and low abundances, thereby enabling the evaluation of assay performance across the expected range of concentrations found in a clinical sample. Using this approach, we show that we are able to confirm the dynamic range and the limit of detection for each DNA microarray platform, RT-PCR protocol, and next-generation sequencer. In addition, the combination of a series of standards and their probes was investigated on each platform, demonstrating that multiplatform calibration and validation is possible.
KW - Cross-platform
KW - DNA microarray
KW - Dynamic range
KW - External RNA standards
KW - Multiplatform calibration
UR - http://www.scopus.com/inward/record.url?scp=84921510286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921510286&partnerID=8YFLogxK
U2 - 10.1016/j.ab.2014.11.012
DO - 10.1016/j.ab.2014.11.012
M3 - Article
C2 - 25481737
AN - SCOPUS:84921510286
SN - 0003-2697
VL - 472
SP - 75
EP - 83
JO - Analytical Biochemistry
JF - Analytical Biochemistry
ER -